In this educational video of the 'How To' series, Fatima Cardoso explains how to treat premenopausal women with ER-positive, HER2-negative metastatic breast cancer. They are typically excluded from the clinical trials and the question of adequate ovarian suppression and inducing menopause is central to enable the possibility for these patients to receive endocrine therapy or any treatment option evaluated in the postmenopausal setting.
Produced by ESMO, oncologypro.esmo.org